Clinical trial · Observational
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy
NCT00792649CI-TRIAL-00001790unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Colonoscopy is the accepted gold standard for screening of colorectal cancer. However, small and flat neoplastic lesions might be overlooked with standard video endoscopes. The new available EPKi system (Pentax, Japan) enables with HD+ imaging resolution above HDTV standard. Aim of the study was to test the efficacy of HD+ colonoscopy alone and in conjunction with I-Scan (newly developed post processing digital filter)in comparison to standard videoendoscopy
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasia | Neoplasm | ALIAS | 0.90 |
| Polyps | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- screening colonoscopy with HD+ endoscopes
- label
- 2
- description
- screening colonoscopy with standardvideoendoscopes
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Consecutive patients scheduled for screening colonoscopy Exclusion Criteria: * Inflammatory bowel disease * Cancer * Pregnancy * Inability to obtain informed consent * Prothrombin time \< 50% of control * Partial thromboplastin time \> 50 seconds
References
Publications (0)
Data not yet available
No reference posted for this study.